Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Hematology/Oncology and Stem Cell Therapy|August 24, 2017
Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: First case reportJonathan H Sin, Mark L ZangardiExpert Opinion on Investigational Drugs|December 4, 2018
Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?Mark L Zangardi, Laura M Spring, Aiko Nagayama, et al.The Oncologist|July 15, 2017
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and RecommendationsLaura M Spring, Mark L Zangardi, Beverly Moy, et al.Expert Review of Clinical Pharmacology|September 7, 2017
Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancerMark L Zangardi, Laura M Spring, Gayle C Blouin, et al.The Oncologist|October 21, 2018
Pilot Randomized Trial of a Pharmacy Intervention for Older Adults with CancerRyan D Nipp, Margaret Ruddy, Charn-Xin Fuh, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 24, 2021
Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter ExperienceSeth A Wander, Hyo S Han, Mark L Zangardi, et al.Pageof 1